Philadelphia, PA (PRWEB) March 26, 2012
The Infrascanner a handheld brain hematoma detector developed by InfraScan, Inc., was announced as the inaugural winner of the Patient Impact Award at Pennsylvania Bio’s Annual Dinner and Awards Celebration, held on March 20 at the Pennsylvania Convention Center
The Infrascanner was introduced in Iraq and Afghanistan to address the need for a non-invasive and portable means for early detection of intracranial hematomas. Intracranial hematomas are a treatable cause of secondary brain injury in patients who have sustained head trauma, and have been reported to occur as the primary injury in 40% of patients with severe head injury. Successful treatment often relies upon timely diagnosis and intervention prior to neurological deterioration. A CT examination is the current clinical standard examination for the detection of intracranial hematomas. However, serial CT scans are not practical, or available in many cases, and require transport to a CT scanner. During field tests with the Infrascanner in Iraq and Afghanistan with the Marines, the lives of a US serviceman and an Afghan boy were saved because doctors were able to detect and treat severe head injuries with the Infrascanner before further complications or brain damage occurred.
Pennsylvania Bio is the only statewide trade association representing Pennsylvania’s entire life sciences industry. Pennsylvania Bio’s Patient Impact Award recognizes a product or organization that has made a significant contribution to the quality of health care or length of life of patients in 2011. Pennsylvania Bio’s annual dinner and awards celebration is the region’s most anticipated and highly attended event for top life science professionals and business executives. For more information on the annual event, please visit http://www.pabio.org/?page_id=646
InfraScan was also selected to receive the MedTech Award for Product Innovation at the 19th Annual Enterprise Awards black-tie gala on Thursday, May 3, 2012 at The Hilton Philadelphia City Avenue Hotel. The black-tie event has been called the “Academy Awards of Business” and is organized by PACT, the Greater Philadelphia Alliance for Capital and Technologies. Attracting more than 1,200 prominent business leaders, the Enterprise Awards black-tie gala celebrates achievement, innovation, and success in the Greater Philadelphia region. An esteemed panel of judges has selected finalists in 10 competitive categories and three medtech honoree categories for the 19th Annual Enterprise Awards from hundreds of nominations. For more information on PACT and the event, please visit http://pact.gpcc.com/
"The InfraScan team is honored and grateful for these two prestigious awards." said Baruch Ben Dor, PhD, president and CEO of InfraScan. He added, "We are delighted to be located in Philadelphia, which is a great place to start Medical Technology companies."
About InfraScan – InfraScan, Inc. is a medical device company that focuses on developing, commercializing, and distributing hand-held diagnostic devices for head injury and stroke assessment based on near infrared (NIR) technology. The company has received early-stage funding from the U.S. Marine Corps, the Office of Naval Research, BioAdvance, the Biotechnology Greenhouse of Southeastern Pennsylvania, the Ben Franklin Technology Partners of Southeastern Pennsylvania, and from the Philadelphia Industrial Development Corporation.